Comparison of 2 Chemotherapy Regimens in Non-Small-Cell Lung Cancer (NSCLC) Patients Relapsing After Surgery and Peri-Operative Chemotherapy. A Randomized Phase III Study.

Trial Profile

Comparison of 2 Chemotherapy Regimens in Non-Small-Cell Lung Cancer (NSCLC) Patients Relapsing After Surgery and Peri-Operative Chemotherapy. A Randomized Phase III Study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs Docetaxel (Primary) ; Carboplatin; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Primary endpoint 'Progression-free-survival-duration' has not been met.
    • 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 31 May 2013 Status changed from active, no longer recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top